Creative Commons Attribution-Noncommercial-Share Alike 3.0
INTRODUCTION
(nucleotides two through seven) of the miRNA is especially important for target site recognition, and miRNAs that share the same seed sequence are grouped into families [1, 2] . Target mRNAs containing complementary "seed matches" as short as six nucleotides in their 3' UTRs can be targeted for repression [3, 4] . Algorithms such as TargetScan (www.TargetScan.org) use seed matches in conjunction with additional sequence features as well as conservation to predict possible mRNA targets of miRNAs [1, 2] . 8 HCV interacts with the miRNA machinery [reviewed in [5] ]. The most abundant liver miRNA, miR-122, binds the HCV 5' UTR, which surprisingly leads to increased HCV RNA abundance [6] . Other miRNAs (miR-122, miR-199a*, miR-196, miR-296, miR-351, miR-431 and miR-448) can also regulate HCV genomic RNA abundance [7] [8] [9] [10] .
In this study, we used Multiplex RT and TaqMan miRNA Assays (Life Technologies) to profile 346 miRNAs by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) in control (uninfected) human liver and liver biopsies from patients with chronic HCV infection (C-HCV). Interestingly, levels of numerous miRNAs were dysregulated in C-HCV relative to uninfected controls. We utilized a novel strategy called Pathway Analysis of Conserved Targets (PACT) to conduct a pathway analysis of predicted targets with a 50% statistical chance of having a conserved miRNA/target interaction (see Materials and Methods). We identified three pathways associated with down-regulated miRNA families. Based on the pathway analysis and miRNA profiling data, we selected the mir-29 family, which consists of mir-29a, mir-29b and mir-29c, for further analysis. Hereafter, we will either indicate the individual miR-29 members or refer to the miR-29 family as miR-29.
Our measurements of miR-29 in purified primary rat hepatocytes and HSCs indicated that both of these cell types contribute roughly equivalent levels of miR-29 to bulk liver. We thus studied the role of miR-29 during HCV infection in hepatocytes and during HSC activation. This study expands the repertoire of miRNAs involved in the HCV lifecycle.
MATERIALS AND METHODS

Materials and Methods contained in Supplemental Web Materials.
RESULTS
C-HCV miRNA expression profiling
We analyzed the expression of 346 miRNAs in liver samples from 22 C-HCV patients and four uninfected controls using multiplex stem-loop RT primers and miRNA qRT-PCR. Patient data and miRNA levels are listed in Supplementary Tables 1 and 2 , respectively. All patients gave informed consent. After normalizing expression values, grouping miRNAs with shared seed regions and filtering for broadly-conserved miRNA families [12] , we selected miRNA families with ~1.4-fold change between HCV patients and the mean of the controls. We filtered for highly expressed miRNA families (top 50% of expression in controls) with consistent expression patterns (up-or down-regulated in >9 C-HCV patients). These relatively strict criteria yielded one consistently up-regulated miRNA family (miR-150) and 11 consistently down-regulated families (Table 2) .
Functional roles of differentially expressed miRNA families
To identify potential roles for the down-regulated miRNA families, we developed a general algorithm called PACT (Pathway Analysis of Conserved Targets) to determine functional categories enriched in targets of co-expressed miRNAs. Recently, we (R. C. F. and C. B. B.) refined the sensitivity and statistical power of TargetScan prediction sufficiently to rank individual targets using a metric called the probability of conserved targeting (P CT ). The P CT controls for seed match type, dinucleotide content and local background conservation. For the set of down-regulated miRNA families, we pooled all predicted target mRNAs with a P CT of at least 0.5, which corresponds to at least a 50% chance of the miRNA/mRNA target relationship being evolutionarily conserved. To correct for the biases caused by selecting predicted targets based on conservation, we generated 20 simulation cohorts of mock miRNAs, selecting mock targets using the same criteria as the true predicted targets (see Supplemental Materials). These background sets were used to estimate the number of predicted miRNA targets found in any particular pathway by chance. We ranked pathways using the Group Enrichment p-value, which is the probability that the given set of miRNAs (e.g., down-regulated miRNAs) have more conserved targets in a pathway than expected by chance, controlling for relevant sources of bias in the P CT where enrichment is the tendency of a set of miRNAs to target a particular biological pathway more than expected at random. Intriguingly, the predicted targets of down-regulated miRNAs were highly enriched in ECM-receptor interaction (p=0.0046) and focal adhesion pathways (p=0.017) ( Table 1, Table 2 ). We next tested whether these enrichments could be due to a general propensity for miRNAs to target these pathways. We calculated a Random Enrichment p-value by repeating the analysis with randomly selected sets of actual miRNAs. We found that the enrichment for the ECM-receptor interaction and focal adhesion pathways was specific to the set of down-regulated miRNA families in Table 2 (p=0.0031 and p= 0.022, respectively).
The focal adhesion category is composed mainly of integrins, laminins, platelet derived growth factor (PDGF) and phosphatidylinositol 3 kinase family (PI3K) members. Laminins mediate ECM attachment, and integrins mediate signaling between the ECM and cell signaling pathways.
PDGF is a powerful HSC mitogen whose signaling is mediated by PI3K. The ECM-receptor interaction category is overwhelmingly composed of ECM components, integrins and laminins.
Thus, HCV infection is associated with a miRNA expression pattern in human liver that derepresses cellular adhesion and ECM genes, which could contribute to C-HCV-mediated fibrogenesis.
Down-regulation of miR-29 in HCV-infected patients
Among the down-regulated miRNA families, miR-29 stood out in several respects: For each miRNA family and significant pathway, we calculated an Individual Enrichment p-value representing the probability of a specific miRNA family having more conserved targets in the pathway than expected by chance. The two most significant pairs were miR-29 targeting ECMreceptor interactions and focal adhesion pathways (Individual Enrichment p=1x10 -32 and 2x10 -7 , respectively). miR-29 also had the largest number of predicted targets in the three significant pathways ( Table 2) , all of which are relevant to HCV pathogenesis. Lastly, all three miR-29 family members were down-regulated in almost all C-HCV-infected patients ( Figure 1A ). resulted in substantially increased fatality due to heart defects [13] .
Contribution of hepatocytes and HSCs to miR-29 levels in bulk liver
The liver is composed of many cell types that could serve as sources of miR-29 expression.
Hepatocytes and HSCs are of special interest to HCV pathogenesis. Hepatocytes compose ~70%
of the cells in the liver and ~78% of the liver mass. HSCs comprise ~8-14% of liver cells [14] , but comprise only ~1.4% of liver mass because of their smaller size [15] . To determine the relative contribution of these two cell types to miR-29 levels in total liver, we measured miR-29 in purified primary rat hepatocytes and freshly isolated HSCs, compared to total liver (Table 3 ).
HSCs expressed much higher levels of miR-29 than hepatocytes (~6.8-to 53-fold higher). Based on cell number or cell mass, hepatocytes outnumber HSCs by ~7-fold or ~55-fold, respectively.
Using these corrections for abundance as well as our measurements of miR-29 in isolated hepatocytes and HSCs, we calculated cell number and cell mass adjusted expression ratios for comparison (Table 3 , 1 = equal contribution). We conclude that both of these cellular compartments likely contribute to miR-29 levels measured in the needle biopsies from patients.
We therefore addressed the role of miR-29 during HCV infection of hepatocytes in culture and during stellate cell activation.
Down-regulation of miR-29 upon acute HCV infection in vitro
First, we assessed the effects of HCV infection on miR-29 expression in hepatocytes using an HCV infectious cell culture model (HCVcc). HCVcc infects, replicates and produces infectious virus in Huh7.5 hepatoma cells [16] . Huh7.5 cells were infected with HCVcc, and ~40% and ~100% of cells were infected at 48 and 96 hours, respectively (data not shown). In agreement with recent reports [17] [18] [19] , HCV infection of Huh7.5 cells down-regulated miR-29 by a factor similar to that observed in C-HCV patients ( Figures 1C-E) . Thus, miR-29 down-regulation in the livers of C-HCV patients may be, at least in part, mediated by HCV infection of hepatocytes.
Modulation of HCV RNA levels by miR-29
To assess whether miR-29 down-regulation is advantageous to the virus, we determined the effects of miR-29 over-expression on levels of HCV genomic RNA in Huh7.5 cells after HCVcc infection. Interestingly, miR-29 over-expression resulted in a ~3-fold decrease in HCV RNA ( Figure 1F ), indicating an anti-viral function. miR-29 over-expression did not cause significant cytotoxicity ( Figure 1G ). These data expand the small repertoire of miRNAs known to regulate HCV [8] [9] [10] [11] and raise the intriguing possibility that HCV may down-regulate miR-29 in order to enhance its fitness.
miR-29 down-regulation during HSC activation
As shown above, freshly isolated HSC express high levels of miR-29 family members, which target multiple transcripts relevant to HSC activation and fibrogenesis. We activated HSCs by plating them on plastic [14] and measured miR-29 expression. miR-29 was rapidly and dramatically down-regulated upon primary rat HSC activation (Figures 2A-C) . Thus, miR-29
down-regulation appears to be a consistent feature of early stellate cell activation. Up-regulated TGF-β by HCV is a primary inducer of HSC activation, so we assessed whether or not TGF-β modulates miR-29 expression in HSCs. Indeed, following TGF-β treatment of LX-2 immortalized human HSCs, miR-29 was down-regulated (Fig. 3A) . In contrast, TGF-β stimulation of hepatocytes (Huh7.5 cells) did not alter miR-29 levels ( Figure 3B ). These results suggest that TGF-β signaling may be one mechanism by which miR-29 is down-regulated during C-HCV infection.
miR-29 over-expression alters HSC proliferation and ECM production
We next examined the effects of miR-29 restoration on features of the activated LX-2 phenotype by transfection of LX-2 cells with miR-29 mimics or negative control mimics. Transfection with Cy3-labeled siRNA indicated >90% transfection efficiency of LX-2 cells (data not shown).
Restoration of miR-29 resulted in a modest (~20%) but statistically significant reduction in proliferation as determined by two separate assays ( Figures 4A and B) . Venugopal et al. between miRNAs and mRNAs to define targets as well as a graph theoretic approach to define miRNA/mRNA modules. They identified 38 miRNA/mRNA regulatory modules that were HCV-associated. Both of these approaches utilized inverse miRNA/mRNA relationships, which can be a powerful tool for uncovering biological relationships, although it does not necessarily identify direct targets. We chose a complementary pathway analysis approach that differed in several fundamental ways from these previous studies.
First, pathway analyses relying on miRNA/mRNA inverse relationships only interrogate interactions resulting in mRNA changes measurable by microarray. Given that miRNAs typically have small effects on individual target mRNAs (<25% change and often much less) [24] , many bona fide miRNA/mRNA interactions may not be observable by inverse expression, i.e., the small direct effects are easily masked by microarray noise or other biological effects. Also, we (R. C. F. and C. B. B.) recently showed that 6-mer seed matches, which produce marginal mRNA abundance changes, were maintained in 3' UTRs in numbers similar to highly effective sites, such as 8-mer seed matches [12] . This observation suggests that many marginally effective 16 sites are nevertheless important enough to be maintained by natural selection. Thus, we analyzed our miRNA expression data using an approach that was independent of inverse miRNA/mRNA relationships. Second, we predicted targets using the P CT conservation metric [12] , which scores sites based on likelihood of preferential conservation over evolutionary time, specifically due to miRNA targeting. By using highly conserved seed matches to predict targets rather than inverse mRNA correlations, we select a relatively small number of targets that have been preserved through millions of years of evolution and may provide a clearer opportunity for biological interpretability. Although species-specific targets cannot be identified using conservation, we can confidently detect targeting relationships of longer-term importance and hence identify pathways involved in miRNA function. Third, we proceed directly from predicted targets to pathway analysis without imposing a requirement on the network structure. Peng et al. explicitly selected bicliques, i.e., completely connected sets of miRNAs and mRNAs; this could preclude detection of regulatory subnetworks in which in aggregate (although perhaps not individually) a set of miRNAs targets many, but not all, members of a functional pathway. Finally, we rigorously controlled for biases in target prediction by explicitly controlling for UTR conservation, seed match number and type, seed match conservation, number of conserved targets specific to the particular miRNA family and implicitly controlling for UTR length and nucleotide composition [12] . Importantly, target predictions that select for genes with seed matches and expression changes select for biased sets of genes with long UTRs (which have more miRNA seed matches by chance) and particular expression levels in the tissue of interest that are more readily detectable by array analysis and therefore render hypergeometric tests for function statistically invalid. Importantly, miRNA pathway analyses have not, to date, accounted for this critical bias. Taken together, our complementary approach was designed to find a small set of confident targets comprising conserved miRNA-pathway interactions in a rigorously controlled manner, leading to a clear biological interpretation and suggesting follow-up experiments.
Down-regulated miRNA families were significantly associated with focal adhesion and ECM receptor interaction pathways (Tables 1 and 2) ; this is intriguing, since these pathways couple intracellular signaling pathways with the ECM. Excess ECM deposition is central to the pathogenesis of HCV. The miR-29 family had the highest enrichment for these pathways with the most significant Individual Enrichment p-value for any pathway of the up-or down-regulated miRNA families (p=1x10 -32 ). Previous reports in other organs implicated miR-29 in numerous processes of potential relevance to C-HCV pathogenesis. miR-29 was previously shown to target ECM components [20] [21] [22] . Van Rooji and coworkers recently showed that miR-29 was downregulated during cardiac fibrosis [20] . Two other reports showed that miR-29b regulates collagen production during osteoblast differentiation [22] and in immortalized LX-2 stellate cells [25] .
Down-regulated miRNAs were also associated with a cancer-related pathway (Tables 1 and 2 ).
miR-29 is dysregulated in a variety of cancers and targets important mediators of metastasis
[reviewed in [26] ]. C-HCV can lead to fibrosis and hepatocellular carcinoma (HCC). Indeed, miR-29 is down-regulated in HCC [19] and is negatively correlated with patient survival [27] . In agreement with our observation, recent studies have established a role for miR-29 and other miRNAs in fibrogenesis of various organs, including heart [20, 30, 31] , kidney [21, 32, 33] , bone [22] and lung [34] ; however, the role of miRNAs in liver fibrosis is only beginning to be explored [reviewed in [35] ]. HSC activation by enhanced TGF-beta and subsequent fibrosis is a major consequence of C-HCV infection. Our pathway analysis pointed to a role for miR-29 in
HSCs. A role for miRNAs during HSC activation is not without precedent. Several studies have implicated miRNAs in regulation of HSC activation, proliferation and apoptosis [36] [37] [38] [39] . We observe up-regulation of miR-150 during C-HCV; this is interesting, since miR-150 was reported to negatively regulate HSC activation [40] . We also observed profound suppression of miR-29 levels upon HSC activation (Figures 2A-C) .
Major aspects of HSC activation include cytoskeletal rearrangements (e.g., α-SMA expression and stress fiber formation), increased proliferation and increased ECM production (e.g., COL1A1
and COL3A1). Venugopal et al. showed that miR-150 and miR-194 were reduced in bile ductligated rats, and over-expression of these miRNAs in LX-2 cells reduced proliferation (by ~25%), increased apoptosis and reduced α-SMA and collagen I levels [40] . Another report showed that miR-27 was up-regulated upon cell culture activation of rat HSCs [39] . HSCs to activate, transdifferentiate and secrete ECM [42] . TGF-β has been shown to downregulate miR-29 expression in cardiac fibroblasts [20] . Here, we show that TGF-β treatment of cultured HSCs resulted in miR-29 down-regulation; this effect appears to be specific to HSCs, shown to be safe [43] , and clinical trials are currently underway to determine whether modulation of miR-122 levels in humans inhibits HCV.
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